Tag: HealthLaw
Fears Nachawati to Represent Maryland’s Calvert County in Opioid Lawsuit
News
Dallas-based Fears Nachawati has been retained by the Calvert County Board of County Commissioners in Maryland to pursue a lawsuit against opioid manufacturers and distributors.
Fears Nachawati Lawyer a Featured Speaker at Opioid Litigation Conference
News
Trial lawyer Jonathan Novak will be a featured speaker at a continuing legal education conference in Austin exploring legal issues surrounding the opioid epidemic.
Making Opioid Antidote Widely Available a Key Step in Treatment
News
Dallas attorney Jeffrey Simon says U.S. Surgeon General Jerome Adams’ call for more Americans to carry the opioid antidote naloxone is one that could save countless lives, and play a key role in addiction recovery.
HIPAA Compliance Checklist Webinar
Event, Oct. 17, 2 p.m. EDT
Compliancy Group will present a webinar on HIPAA compliance. The event will be Tuesday, Oct. 17, at 2 p.m. ED
Key Commercial Questions When Contracting for Digital Health Solutions
Insight
Covington’s Digital Health team considers some key questions that companies across the life sciences, technology, and communications industries should be asking as they seek to fit together the regulatory and commercial pieces of the complex digital health puzzle.
HIPAA 101: The 30-Minute Guide to Understanding Compliance
Event, June 27, 2 p.m. EDT
Compliancy Group will present a free webinar on HIPAA compliance, titled “The 30-Minute Guide to Understanding Compliance.”
Health Law: Is Your Arbitration Agreement Enforceable?
Insight
A recent decision of the Arizona Court of Appeals provides guidance for evaluation of the enforceability of arbitration agreements in the health care field, reports Snell & Wilmer in its Health Law Checkup blog.
Healthcare and the False Claims Act, 2016 Survey
Insight
Healthcare and the False Claims Act, 2016 Survey summarizes the important laws, regulations, pronouncements, and cases of the past year, to inform healthcare providers and healthcare attorneys on this crucial statute in the healthcare industry.
Painful Verdicts for Johnson & Johnson
News
The Lanier Law Firm said these verdicts marked the second and third bellwether trials among thousands of similar lawsuits nationwide that have been consolidated in multidistrict litigation in the U.S. District Court for the Northern District of Texas.
Obamacare Repeal: 18 Million Lose Insurance, Premiums Soar: Report
News
NBC News is reporting that about 18 million people would lose or drop their health insurance in the first year after Obamacare is repealed, the Congressional Budget Office reported Tuesday.
Johnson & Johnson Hit With Over $1 Billion Verdict on Hip Implants
News
The New Jersey pharmaceutical and medical device maker and its DePuy Orthopaedics subsidiary must pay damages to six California plaintiffs who say they suffered serious chronic and painful medical problems caused by the device, reports The Dallas Morning News.
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
News
The antitrust investigation by the Justice Department spans more than a dozen companies and about two dozen drugs, reports Bloomberg.
Alabama Law Firm Says It Has Received 26k Calls After Talcum Powder Verdicts
News
A law firm in Montgomery, Ala., says it received nearly 26,000 phone calls from people inquiring about a possible link between talcum powder and ovarian cancer after its clients won a total of $127 million in two verdicts earlier this year, reports AL.com.
Theranos Walks Away From Zika Test
News
The move is another setback for the Palo Alto, Calif., company as it tries to recover from crippling regulatory sanctions that followed revelations by The Wall Street Journal of shortcomings in Theranos’s technology and operations.
Ex-Johnson & Johnson Unit Execs Guilty of Misdemeanors, Avoid Felony Convictions
News
The jury acquitted the two defendants on felony charges of wire fraud and conspiracy, finding they did not act with intent to defraud or mislead. But the two former executives were convicted on charges of promoting a product for an unapproved use, Reuters reports.
U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers
News
U.S. Attorney General Loretta E. Lynch said the proposed mergers “would leave much of the multitrillion-dollar health insurance industry in the hands of three mammoth insurance companies,” reports The New York Times.
Theranos CEO Holmes Banned From Operating a Lab for 2 Years
News
Theranos Inc.’s Chief Executive Officer Elizabeth Holmes was banned for two years from owning or operating laboratories by U.S. regulators, a major blow against the controversial blood-testing startup that’s come under scrutiny for risking patient harm with unreliable tests, reports Doni Bloomfield for Bloomberg Technology.
A Leak Wounded This Company. Fighting the Feds Finished It Off
NEWS
LabMD’s future changed one day in 2008 when the company’s general manager received a phone call from a man who claimed to be in possession of a file containing patient information, including more than 9,000 Social Security numbers, reports Bloomberg.
Blood-Testing Company Theranos Is Subject of Criminal Probe by U.S.
News
Federal prosecutors have launched a criminal investigation into whether Theranos Inc. misled investors about the state of its technology and operations, according to people familiar with the matter, The Wall Street Journal is reporting.
Abbott Wins in $1 Billion Trial Over Marketing of Stents
News
Abbott Laboratories didn’t cause medical providers to submit false payment claims to Medicare for unapproved stents, a Texas jury ruled, thwarting a whistle-blower’s lawsuit seeking as much as $1 billion, reports Bloomberg.
